SHP2 inhibitor monotherapy and uses thereof
US12390469B2 · kind B2 · utility
0Cited by
10References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 4, 2022 |
| Grant date | Aug 19, 2025 |
| Priority date | — |
| Expiry date | May 4, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are SHP2 inhibitors for use in the reduction of solid tumors in a method of treating cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.